Literature DB >> 16123685

Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003.

Alice M Tang1, Denise L Jacobson, Donna Spiegelman, Tamsin A Knox, Christine Wanke.   

Abstract

Although the incidence of most AIDS-defining opportunistic infections, including HIV wasting syndrome, has dramatically decreased since the introduction of highly active antiretroviral therapy (HAART), previous studies have shown that weight loss and wasting are still common in HIV-infected persons. We examined the 6-month risk and determinants of > or =5% weight loss during the period when the use of combination antiretroviral therapy and HAART was commonplace among 713 participants enrolled in the Nutrition for Healthy Living cohort in Boston, Massachusetts between 1995 and 2003. There was a significant 50% increase in the 6-month risk of > or =5% weight loss in the later HAART years (1998-2003) compared with the early HAART years (1995-1997) among most of the participants who reported they were not trying to lose weight (P = 0.002). In addition to calendar time, several other variables were significantly independently associated with risk of > or =5% weight loss, including use of injection drugs; living below the federal poverty level; higher body mass index (BMI; > or =25 kg/m(2)); lower CD4 cell count; higher HIV viral load; and presence of diarrhea, nausea, or fever. The characteristics of weight loss in the later HAART years did not differ from the early HAART years with respect to initial body composition (eg, weight, BMI, triceps skinfold thickness) or changes in body composition during the periods of weight loss. In summary, we have found that the risk of > or =5% unintentional weight loss over 6-month intervals is on the rise in our cohort of HIV-infected participants, despite better control of HIV infection in recent years. Although we still do not know the exact cause of this increase, the fact that it exists indicates the need for clinicians who take care of HIV-infected patients to continue to pay attention to weight loss among particular segments of their patient population. This is particularly important because recent studies have shown that even a 5% weight loss in 6 months markedly increases the risk of death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123685     DOI: 10.1097/01.qai.0000159627.54149.2e

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

1.  Decreased myoblast differentiation in chronic binge alcohol-administered simian immunodeficiency virus-infected male macaques: role of decreased miR-206.

Authors:  L Simon; S M Ford; K Song; P Berner; C Vande Stouwe; S Nelson; G J Bagby; P E Molina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-06-21       Impact factor: 3.619

2.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

3.  Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Authors:  Denise L Jacobson; Donna Spiegelman; Tamsin K Knox; Ira B Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

4.  Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania.

Authors:  Helen Semu; Rachel M Zack; Enju Liu; Ellen Hertzmark; Donna Spiegelman; Kevin Sztam; Claudia Hawkins; Guerino Chalamila; Aisa Muya; Hellen Siril; Ramadhani Mwiru; Deo Mtasiwa; Wafaie Fawzi
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-08-21

5.  Interactive effects of HIV/AIDS, body mass, and substance abuse on the frontal brain: a P300 study.

Authors:  Lance O Bauer
Journal:  Psychiatry Res       Date:  2010-05-23       Impact factor: 3.222

6.  Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.

Authors:  Kevin E Yarasheski; Rebecca Scherzer; Donald P Kotler; Adrian S Dobs; Phyllis C Tien; Cora E Lewis; Richard A Kronmal; Steven B Heymsfield; Peter Bacchetti; Carl Grunfeld
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-10       Impact factor: 6.053

7.  Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.

Authors:  Fred R Sattler; Natasa Rajicic; Kathleen Mulligan; Kevin E Yarasheski; Susan L Koletar; Andrew Zolopa; Beverly Alston Smith; Robert Zackin; Bruce Bistrian
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

8.  Psychiatric and neurophysiological predictors of obesity in HIV/AIDS.

Authors:  Lance O Bauer
Journal:  Psychophysiology       Date:  2008-09-24       Impact factor: 4.016

9.  Increasing rates of obesity among HIV-infected persons during the HIV epidemic.

Authors:  Nancy Crum-Cianflone; Mollie Poehlman Roediger; Lynn Eberly; Maryam Headd; Vincent Marconi; Anuradha Ganesan; Amy Weintrob; R Vincent Barthel; Susan Fraser; Brian K Agan
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

Review 10.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.